Our work thoroughly and systematically shows that autophagy/lysosome/mTOR-associated molecules might be useful markers for monitoring the effects of potential therapeutic approaches beyond GM2 gangliosidosis. The gene discussed is MTOR; the disease is GM2 gangliosidosis.